Showing results (41-50 of 170) with videos related to
Sort By:
Pageof 17
Frontiers in Immunology|January 21, 2025
SILAC-based quantification reveals modulation of the immunopeptidome in BRAF and MEK inhibitor sensitive and resistant melanoma cellsMelissa Bernhardt, Anne Rech, Marion Berthold, et al.Healthcare (Basel, Switzerland)|September 14, 2024
Exploring the Thoughts, Needs and Fears of Chemotherapy Patients-An Analysis Based on Google Search BehaviorDeniz Özistanbullu, Ronja Weber, Maria Schröder, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 29, 2013
Cutting edge: An inactive chromatin configuration at the IL-10 locus in human neutrophilsNicola Tamassia, Maili Zimmermann, Monica Castellucci, et al.European Journal of Cancer (Oxford, England : 1990)|April 2, 2022
MAPKinase inhibition after failure of immune checkpoint blockade in patients with advanced melanoma - An evaluation of the multicenter prospective skin cancer registry ADOREGSophia Kreft, Valerie Glutsch, Anne Zaremba, et al.Dermatology and Therapy|November 5, 2025
HDR Mould-Based Brachytherapy for Cutaneous Neoplasms: Toxicity, Long-Term Control, Cosmesis and PROMsMarkus Diefenhardt, Nikolaos Tselis, Julia Achenbach, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 30, 2025
Brentuximab vedotin and radiotherapy for CD30-positive cutaneous T-cell lymphoma - a retrospective multicenter analysisPatrick Schummer, Caroline Glatzel, Philipp Schrüfer, et al.European Journal of Cancer (Oxford, England : 1990)|September 11, 2016
Checkpoint inhibitors in chronic kidney failure and an organ transplant recipientSaskia Herz, Thomas Höfer, Matina Papapanagiotou, et al.Advances in Therapy|July 9, 2020
Patients with BRAF-Mutant Advanced/Metastatic Melanoma: Original Research on the Treatment Reality in Germany and Austria in the Era of ChoiceSebastian Haferkamp, Mareike Alter, Dirk Debus, et al.International Journal of Cancer|December 1, 2015
Type I IFNs induce anti-tumor polarization of tumor associated neutrophils in mice and humanLisa Andzinski, Nadine Kasnitz, Stephanie Stahnke, et al.Plos One|November 22, 2013
TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinomaKlaus G Griewank, Rajmohan Murali, Bastian Schilling, et al.Pageof 17